Pharma Focus Asia
KP - Sustainable Packaging Solutions

Cambrex to Expand Its Edinburgh Screening Facility

Introduction:

Cambrex corporation announced plans to expand its facility in Edinburgh, Scotland, doubling the current footprint to 15,000 square feet.

Features:

Currently, Cambrex's Edinburgh facility provides solid form development services, including investigations such as salt, co-crystal and polymorph screening, as well as crystallisation process development and GMP analytical services.

The additional instruments and reactors for large-scale crystallisation studies and solid form screening capabilities will be the new features of the expanded facility.

Additionally, the company plans to install Ultra-Performance Liquid Chromatography (UPLC) and gas chromatography instruments, as well as additional Process Analytical Technology (PAT) tools.

The project is expected to be completed by the end of the year.

Specifications:

NameCambrex Corporation
LocationEdinburgh, Scotland
TypeExpansion
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?